Aarti Drugs Limited — Others, 12-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aarti Drugs has received a certificate from its Registrar and Share Transfer Agent, MUFG Intime India, confirming that all securities submitted for dematerialisation during the quarter have been processed—either accepted or rejected—and the corresponding certificates have been cancelled. The dematerialised securities are now listed on the stock exchanges where the company’s existing shares trade. This update ensures smooth share transfer and reflects ongoing compliance with shareholding and listing processes, supporting shareholder convenience and market transparency.